CCRCC
Clinical trials for CCRCC explained in plain language.
Never miss a new study
Get alerted when new CCRCC trials appear
Sign up with your email to follow new studies for CCRCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation therapy shows promise for Hard-to-Treat kidney cancer
Disease control Recruiting nowThis study tests a new drug, 177Lu-TLX250, which delivers radiation directly to kidney cancer cells that have a specific marker (CAIX). It is for adults with advanced clear cell kidney cancer that has come back or not responded to at least two prior treatments. The trial compares…
Matched conditions: CCRCC
Phase: PHASE3 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New hope for advanced kidney cancer: first human trial of NEO-811 begins
Disease control Recruiting nowThis early-phase study tests a new drug called NEO-811 in about 30 people with advanced clear cell kidney cancer that cannot be removed by surgery. The main goals are to find a safe dose and check for side effects. Participants must have tried or refused standard treatments.
Matched conditions: CCRCC
Phase: PHASE1 • Sponsor: Neomorph, Inc • Aim: Disease control
Last updated May 18, 2026 12:03 UTC